Pfizer Inc.
PFE
$27.05
$0.291.08%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/28/2026 | 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | |
|---|---|---|---|---|---|
| Net Income | -109.19% | 263.05% | -146.53% | -- | -- |
| Total Depreciation and Amortization | 0.06% | -3.01% | 0.12% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,474.00% | -98.67% | 767.74% | -- | -- |
| Change in Net Operating Assets | -4.85% | -208.93% | 4,516.67% | -- | -- |
| Cash from Operations | -68.07% | -51.10% | 16.19% | -- | -- |
| Capital Expenditure | -22.25% | 48.40% | -40.37% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.13% | -24.91% | 188.95% | -- | -- |
| Cash from Investing | 168.28% | 112.77% | -152.92% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -833.86% | 95.63% | -48,533.33% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.25% | 0.00% | -0.04% | -- | -- |
| Other Financing Activities | 90.85% | -545.45% | -12.82% | -- | -- |
| Cash from Financing | -28.26% | -579.19% | 124.06% | -- | -- |
| Foreign Exchange rate Adjustments | -121.05% | 280.00% | 150.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.95% | 385.79% | 34.33% | -- | -- |